IGF2 and breast cancer: In particular, human MCF7 BC cells, knocked out for IGF1R and stably overexpressing human oncofetal IR-A (MCF7IGF1R-ve/IR-A), acquired increased aerobic glycolysis associated with increased mitochondrial biogenesis and activity, which promoted high cell proliferation and invasion when exposed to either insulin or IGF2 [8].